About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1630 record(s)
Req # A-2023-000874
Adverse Drug Reactions (ADRs). Report numbers: 001055861, 001055864, 001055869, 001055871.Organization: Health Canada
December 2023
Req # A-2023-000876
Adverse Drug Reaction (ADR) for Morphine. Report number: E2B_06527804. ADR for Naltrexone. Report number: 001050594. ADRs for Heparin. Report numbers: 001048584, 001050673.Organization: Health Canada
December 2023
Req # A-2023-000893
Adverse Drug Reactions (ADRs). Report numbers: 000953883, 000977338, E2B_03492652, E2B_03492634, E2B_03534201, E2B_03915037, 000930082, E2B_03098071, 000943742, 000963342.Organization: Health Canada
December 2023
Req # A-2023-000910
Adverse Drug Reactions (ADRs) for Immunoglobulin (human). Report numbers: E2B_06484002, E2B_06487392, E2B_06521406. ADR for C1 Esterase Inhibitor. Report number: E2B_06524635. ADR for Antihmophilic factor (human). Report number: E2B_06490190. ADR…Organization: Health Canada
December 2023
Req # A-2023-000930
Adverse Drug Reactions (ADRs). Report numbers: 001008139, 001012256, 001012304, 001014020, E2B_04005601, 000966661, E2B_05866227, E2B_04549448, E2B_05535616, E2B_05656792.Organization: Health Canada
December 2023
Req # A-2023-000949
Adverse Drug Reactions (ADRs). Report numbers: E2B_06260333, 001035819, 001035617, E2B_06244064, E2B_02790669, 001034963, 001035446, 001035583, 001035529, 001039301.Organization: Health Canada
December 2023
Req # A-2023-000955
Adverse Drug Reactions (ADRs). Report numbers: E2B_06336965, E2B_06402151, E2B_06399745, E2B_06404345, 001035620, E2B_06375857, E2B_05712679, 000954222, 000953433, 000947156.Organization: Health Canada
December 2023
Req # A-2023-000998
Adverse Drug Reactions (ADRs). Report numbers: 001025659, 001036848, E2B_06212312.Organization: Health Canada
December 2023
Req # A-2023-001037
Adverse Drug Reaction (ADR). Report number: E2B_06559459.Organization: Health Canada
December 2023
Req # A-2023-001095
Adverse Drug Reaction (ADR). Report number: 001065166.Organization: Health Canada
December 2023